Collaborative intelligence to transform healthcare services digitally.
FDA OKs First Interchangeable Biosimilars for Denosumab
The FDA approved injectable Jubbonti and Wyost as the first interchangeable biosimilars to denosumab (Prolia, Xgeva), and for all the same indications, including the prevention